Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Recent & Breaking News (NDAQ:APHA)

The StockTalk Cannabis Report: Apr 10, 2020

Dave Jackson April 10, 2020

Aphria Inc. to Announce Third Quarter Fiscal 2020 Financial Results on April 15, 2020

PR Newswire April 9, 2020

The StockTalk Cannabis Report: Apr 3, 2020. No Fools Day.

Dave Jackson April 3, 2020

The StockTalk Cannabis Report: Mar 27, 2020.

Dave Jackson March 27, 2020

Aphria Inc. Recognized for Executive Gender Diversity by Globe and Mail's Women Lead Here Benchmark and Provides an Update on COVID-19

Canada NewsWire March 27, 2020

The StockTalk Cannabis Report: Mar 20, 2020. In the Green Again.

Dave Jackson March 20, 2020

Cannabis stocks jump as report suggests sales climbing amid COVID-19 pandemic

Stockhouse Editorial March 19, 2020

The StockTalk Cannabis Report: Mar 13, 2020. Keep Calm and Carry On Edition.

Dave Jackson March 13, 2020

Analyst: How to cash the best asset to help pot producers withstand disruption from COVID-19

Stockhouse Editorial March 9, 2020

Pot Stocks Decline Amid Broader Market Tumble

Stockhouse Editorial March 6, 2020

The StockTalk Cannabis Report: Mar 6, 2020

Dave Jackson March 6, 2020

The Top Cannabis Bullboards: Jan - Feb 2020

Stockhouse Editorial March 3, 2020

The StockTalk Cannabis Report: Feb 28, 2020

Dave Jackson February 28, 2020

The StockTalk Cannabis Report: Feb 21, 2020

Dave Jackson February 21, 2020

The StockTalk Cannabis Report: Feb 14, 2020

Dave Jackson February 14, 2020

The StockTalk Cannabis Report: Feb 7, 2020

Dave Jackson February 7, 2020

Aphria Inc. Announces Closing of $100 Million Strategic Investment from Institutional Investor

Canada NewsWire January 31, 2020

The StockTalk Cannabis Report: Jan. 31, 2020

Dave Jackson January 31, 2020

Aphria Inc. Enters Into Agreement to Receive $100 Million Strategic Investment from Institutional Investor

Canada NewsWire January 24, 2020

The StockTalk Cannabis Report: Jan. 24, 2020

Dave Jackson January 24, 2020